Tricycle Day
Get smarter about psychedelics. Our thrice-weekly newsletter serves you the top stories in psychedelic research 🔬, policy 🏛️, and business 📈, and it's actually fun to read. 🫠
I consent to receive newsletters via email. Sign up Terms of service.
Tap into our mycelial network.
[5-min read] Arizona-funded clinical trial will test whole psilocybin mushrooms for PTSD.
[5-min read] Q&A with Raghu Markus, Seeker & Producer
[3-min read] Facilitators comment on the ideal age range for psychedelic use.
[5-min read] Ketamine company receives one of nine FDA Commissioner's National Priority Vouchers.
[5-min read] Q&A with Joe Moore, CEO & Cofounder
[3-min read] Psychedelic facilitators explain when to journey with support and when to go solo.
[5-min read] atai receives FDA's sixth breakthrough therapy designation for a psychedelic drug.
[5-min read] Q&A with Mikki Vogt, Clinical Facilitator & Founder
[3-min read] Facilitators weigh in on whether to proceed with a psychedelic session after experiencing trauma.
[5-min read] Crossover trial examines the key differences between MDMA and MDA.
[5-min read] Q&A with Greg Fonzo, Psychologist & Researcher
[3-min read] Psychedelic facilitators explain how to connect with spirit guides.
